Statements (124)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Cell
gptkb:surgery gptkb:brand |
| gptkbp:administered_by |
gptkb:surgery
|
| gptkbp:advocacy |
important for awareness
required before treatment |
| gptkbp:approves |
gptkb:2010
gptkb:European_Union |
| gptkbp:associated_with |
reduction of pain
|
| gptkbp:available_in |
multiple European countries
|
| gptkbp:biological_properties |
promote healing
|
| gptkbp:biological_source |
autologous cells
|
| gptkbp:clinical_guidelines_update |
ongoing process
|
| gptkbp:clinical_integration |
into orthopedic practices
|
| gptkbp:clinical_outcome_measures |
used in studies
|
| gptkbp:clinical_trial |
Phase III
ongoing studies positive efficacy specific inclusion criteria conducted in Europe multiple sites across Europe supporting its use |
| gptkbp:clinical_use |
orthopedic surgery
required for administration evolving with new data integrated into orthopedic protocols |
| gptkbp:collaboration |
research institutions
|
| gptkbp:collaborations |
with research institutions
with universities and hospitals |
| gptkbp:competitors |
other cartilage repair products
|
| gptkbp:contains |
chondrocytes
autologous chondrocytes cultured chondrocytes |
| gptkbp:contraindication |
active joint infection
|
| gptkbp:customer_satisfaction |
generally high
measured post-treatment |
| gptkbp:developed_by |
gptkb:Ti_Genix
chondrocytes |
| gptkbp:duration |
varies by patient
|
| gptkbp:eligibility |
age 18-65
|
| gptkbp:events |
gptkb:Rehabilitation_services
necessary after treatment |
| gptkbp:feedback |
generally positive
|
| gptkbp:funding |
public and private sources
sought for further studies |
| gptkbp:future_prospects |
improving outcomes
focused on improving techniques |
| https://www.w3.org/2000/01/rdf-schema#label |
Chondro Celect
|
| gptkbp:indication |
articular cartilage repair
knee cartilage repair articular cartilage defects |
| gptkbp:informed_decision |
critical for patients
|
| gptkbp:invention |
patented technology
held by Ti Genix |
| gptkbp:involves |
cell culture process
|
| gptkbp:is_compared_to |
microfracture technique
|
| gptkbp:is_effective_against |
improved joint function
|
| gptkbp:is_used_for |
cartilage repair
|
| gptkbp:long_term_outcome |
joint preservation
sustained improvement |
| gptkbp:manufactured_from |
patient's own cartilage cells
|
| gptkbp:manufacturing_process |
cell culture
|
| gptkbp:market |
ongoing studies
depends on local regulations |
| gptkbp:market_position |
available in select countries
|
| gptkbp:marketed_as |
gptkb:Belgium
gptkb:Germany gptkb:Netherlands Chondro Celect name Chondro Celect brand name |
| gptkbp:mechanism_of_action |
regeneration of cartilage
regeneration of cartilage tissue |
| gptkbp:part_of |
regenerative medicine field
|
| gptkbp:partnerships |
with hospitals and clinics
|
| gptkbp:patient_education |
important for treatment success
important for informed consent |
| gptkbp:price |
varies by region
|
| gptkbp:product_quality |
stringent standards
|
| gptkbp:provides_guidance_on |
recommended for specific cases
based on evidence |
| gptkbp:publication |
numerous peer-reviewed articles
|
| gptkbp:recruitment |
critical for outcomes
age and activity level based on imaging studies |
| gptkbp:regulatory_body |
gptkb:European_Medicines_Agency
|
| gptkbp:regulatory_compliance |
CE marked
requires clinical data |
| gptkbp:requires |
surgical intervention
|
| gptkbp:research_focus |
cartilage regeneration
cartilage repair technologies |
| gptkbp:safety_features |
generally well tolerated
|
| gptkbp:side_effect |
pain
stiffness swelling minimal reported |
| gptkbp:specialties |
physical therapy
developed for implantation |
| gptkbp:storage |
cryopreserved
|
| gptkbp:success_rate |
high in selected patients
|
| gptkbp:target_audience |
patients with knee cartilage damage
|
| gptkbp:training |
essential for success
for healthcare providers surgeon training needed |
| gptkbp:treatment |
monitored over time
evaluated in studies varies by study improved joint function standardized for consistency autologous chondrocyte implantation restore cartilage restore cartilage function |
| gptkbp:treatment_follow_up |
regular assessments required
|
| gptkbp:treatment_innovation |
continuously evolving.
advancements in cell therapy |
| gptkbp:treatment_limitations |
not suitable for all patients
|
| gptkbp:type_of |
gptkb:Cell
autologous chondrocyte implantation cell-based therapy |
| gptkbp:type_of_insurance |
varies by country
may vary |
| gptkbp:used_for |
cartilage repair
treatment of cartilage defects |
| gptkbp:bfsParent |
gptkb:Ti_Genix
|
| gptkbp:bfsLayer |
5
|